Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+11.16%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$14.6B
AUM Growth
+$4.4B
(+43%)
Cap. Flow
+$3.44B
Cap. Flow
% of AUM
23.49%
Top 10 Holdings %
Top 10 Hldgs %
34.38%
Holding
1,185
New
178
Increased
767
Reduced
213
Closed
26
Top Buys
| 1 |
A10 Networks
ATEN
|
+$221M |
| 2 |
Texas Instruments
TXN
|
+$158M |
| 3 |
Qualcomm
QCOM
|
+$154M |
| 4 |
NVIDIA
NVDA
|
+$143M |
| 5 |
Broadcom
AVGO
|
+$131M |
Top Sells
| 1 |
VanEck Gold Miners ETF
GDX
|
+$89.7M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$49.5M |
| 3 |
Apple
AAPL
|
+$21.2M |
| 4 |
Microsoft
MSFT
|
+$17.7M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$15.7M |
Sector Composition
| 1 | Technology | 33.57% |
| 2 | Financials | 17.43% |
| 3 | Healthcare | 6.14% |
| 4 | Energy | 3.08% |
| 5 | Industrials | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Trimble
TRMB
$19.2B
| $2.83M | 0.02% |
+36,412
| New | +$2.83M |
|
527
Atara Biotherapeutics
ATRA
$83.2M
| $2.83M | 0.02% |
7,885
+7,023
| +815% | +$2.52M |
|
528
Ionis Pharmaceuticals
IONS
$10.2B
| $2.83M | 0.02% |
62,884
+42,536
| +209% | +$1.91M |
|
529
Altimmune
ALT
$326M
| $2.81M | 0.02% |
+198,798
| New | +$2.81M |
|
530
Champion Homes, Inc.
SKY
$4.18B
| $2.81M | 0.02% |
61,978
-16,412
| -21% | -$743K |
|
531
Erie Indemnity
ERIE
$17.3B
| $2.8M | 0.02% |
12,667
+2,240
| +21% | +$495K |
|
532
Workhorse Group
WKHS
$17.7M
| $2.8M | 0.02% |
813
+696
| +595% | +$2.39M |
|
|
BHVN
533
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.79M | 0.02% |
40,868
+30,188
| +283% | +$2.06M |
|
534
VirnetX
VHC
$76.9M
| $2.79M | 0.02% |
25,037
+21,422
| +593% | +$2.39M |
|
535
Regenxbio
RGNX
$501M
| $2.79M | 0.02% |
81,709
+69,400
| +564% | +$2.37M |
|
536
United Bankshares
UBSI
$5.38B
| $2.79M | 0.02% |
72,219
+50,092
| +226% | +$1.93M |
|
537
Arcturus Therapeutics
ARCT
$485M
| $2.78M | 0.02% |
67,346
+58,551
| +666% | +$2.42M |
|
538
Live Oak Bancshares
LOB
$1.69B
| $2.77M | 0.02% |
40,489
+29,156
| +257% | +$2M |
|
539
Community Bank
CBU
$3.14B
| $2.77M | 0.02% |
36,120
+26,813
| +288% | +$2.06M |
|
540
Ares Management
ARES
$39.3B
| $2.77M | 0.02% |
49,429
+8,755
| +22% | +$491K |
|
541
Rocket Pharmaceuticals
RCKT
$351M
| $2.76M | 0.02% |
62,133
+55,163
| +791% | +$2.45M |
|
|
TPTX
542
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.75M | 0.02% |
29,058
+21,199
| +270% | +$2.01M |
|
|
AXDX
543
DELISTED
Accelerate Diagnostics
AXDX
| $2.74M | 0.02% |
32,955
+28,197
| +593% | +$2.35M |
|
544
Generation Bio
GBIO
$40.9M
| $2.73M | 0.02% |
+9,588
| New | +$2.73M |
|
545
Beam Therapeutics
BEAM
$2.08B
| $2.71M | 0.02% |
33,854
+23,029
| +213% | +$1.84M |
|
546
Interactive Brokers
IBKR
$27.9B
| $2.7M | 0.02% |
147,836
+26,176
| +22% | +$478K |
|
547
PTC Therapeutics
PTCT
$4.64B
| $2.7M | 0.02% |
57,004
+42,657
| +297% | +$2.02M |
|
|
SRNE
548
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.69M | 0.02% |
325,063
+206,611
| +174% | +$1.71M |
|
549
Simon Property Group
SPG
$58.5B
| $2.69M | 0.02% |
23,610
+10,748
| +84% | +$1.22M |
|
550
BioCryst Pharmaceuticals
BCRX
$1.69B
| $2.68M | 0.02% |
263,584
+151,233
| +135% | +$1.54M |
|